fingolimod hydrochloride has been researched along with fluorescein-5-isothiocyanate in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (fluorescein-5-isothiocyanate) | Trials (fluorescein-5-isothiocyanate) | Recent Studies (post-2010) (fluorescein-5-isothiocyanate) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 8,493 | 33 | 2,090 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Enosawa, S; Ikekita, M; Nagahara, Y; Shinomiya, T; Suzuki, S | 1 |
1 other study(ies) available for fingolimod hydrochloride and fluorescein-5-isothiocyanate
Article | Year |
---|---|
Evidence that FTY720 induces T cell apoptosis in vivo.
Topics: Administration, Oral; Animals; Annexin A5; Apoptosis; B-Lymphocytes; Cell Separation; Dose-Response Relationship, Drug; Down-Regulation; Fingolimod Hydrochloride; Fluorescein-5-isothiocyanate; Granulocytes; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Monocytes; Propylene Glycols; Rats; Rats, Inbred Lew; Sphingosine; T-Lymphocytes | 2000 |